Genomic characterization of colitis-associated colorectal cancer

Table 1 Risk and protective factors for CAC patients

Risk factors	Protective factors
Young age onset	Folic acid use
Family history of sporadic CRC	UDCA use (in patients with PSC)
Long duration of IBD	5-ASA treatment
Increased extent of colitis	Colectomy
PSC	Compliance with CRC surveillance
Severity of colitis
Pseudopolyps
Dysplasia in UC

CAC colitis-associated cancer, CRC colorectal cancer, UDCA ursodeoxycholic acid, IBD inflammatory bowel disease, 5-ASA 5-aminosalicylic acid, PSC primary sclerosing cholangitis, UC ulcerative colitis

ISSN: 1477-7819